Effect of paclitaxel and mesenchymal stem cells seeding on ex vivo vascular endothelial repair and smooth muscle cells growth

Journal of Cardiovascular Pharmacology

Volumn 46, Issue 6, 2005, Pages 779-786

  Wu, Xiaojing ^a   Huang, Lan ^a   Zhou, Qi ^a   Song, Yaoming ^a   Li, Aimin ^a   Wang, Hong ^a   Song, Mingbao ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Co culture; Endothelial cell; Growth; Paclitaxel; Smooth muscle cell; Stem cell

Indexed keywords

PACLITAXEL; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; COCULTURE; DRUG EFFECT; ENDOTHELIUM CELL; EX VIVO STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE FIBER; TISSUE REPAIR; VASCULAR ENDOTHELIUM; ANIMAL; CELL CULTURE; CELL LINEAGE; CYTOLOGY; PHYSIOLOGY; STEM CELL; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; HUMANS; MALE; MESENCHYMAL STEM CELLS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PACLITAXEL; RABBITS; STEM CELLS;

EID: 33644664486     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000187940.14102.64     Document Type: Article

References (35)

1. El-Omar MM, Dangas G, Iakovou I, et al. Update on in-stent restenosis. Curr Interv Cardiol Rep. 2001;3:296-305.
2. Lowe HC, Oesterle SN, Khachigian LM. Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol. 2002;39:183-193.
3. Grube E, Silber S, Hauptmann KE, et al. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation. 2003;107:38-42.
4. Weissman NJ, Koglin J, Cox DA, et al. Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. J Am Coll Cardiol. 2005;45:1201-1205.
5. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126-2130.
6. Virmani R, Liistro F, Stankovic G, et al. Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation. 2002;106:2649-2651.
7. Losordo DW, Isner JM, Diaz-Sandoval LJ. Endothelial recovery the next target in restenosis prevention. Circulation. 2003;107:2635-2637.
8. Colter DC, Sekiya I, Prockop DJ. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci USA. 2001;98:7841-7845.
9. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med. 2003;9:702-712.
10. Kipshidze N, Ferguson JJ, Keelan MH Jr, et al. Endoluminal reconstruction of the arterial wall with endothelial cell/glue matrix reduces restenosis in an atherosclerotic rabbit. J Am Coll Cardiol. 2000;36:1396-1403.
11. Grobmyer SR, Kuo A, Orishimo M, et al. Determinants of binding and internalization of tissue-type plasminogen activator by human vascular smooth muscle and endothelial cells. J Biol Chem. 1993;268:13291-13300.
12. Wei EH, Rao MR, Chen XY, et al. Inhibitory effects of praeruptorin C on cattle aortic smooth muscle cell proliferation. Acta Pharmacol Sin. 2002;23:129-132.
13. Del Giglio A, Drach J, Kornblau SM, et al. Quantitative expression of proliferating cell nuclear antigen by western blot (PCNAWB) in peripheral blasts correlates with remission induction in patients with acute myelogenous leukemia. Leuk Lymphoma. 1995;19:235-241.
14. Trochon V, Mabilat C, Bertrand P, et al. Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro. Int J Cancer. 1996;66:664-668.
15. Gorog P, Kovacs IB. Inhibition of vascular smooth muscle cell migration by intact endothelium is nitric oxide-mediated: interference by oxidised low density lipoproteins. J Vasc Res. 1998;35:165-169.
16. Saito T, Kuang JQ, Bittira B, et al. Xenotransplant cardiac chimera: immune tolerance of adult stem cells. Ann Thorac Surg. 2002;74:19-24.
17. Fandrich F, Lin X, Chai GX, et al. Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat Med. 2002;8:171-178.
18. Herdeg C, Oberhoff M, Karsch KR. Antiproliferative stent coatings: taxol and related compounds. Semin Interv Cardiol. 1998;3:197-199.
19. Frixione E. Recurring views on the structure and function of the cytoskeleton: a 300-year epic. Cell Motil Cytoskeleton. 2000;46:73-94.
20. Creel CJ, Lovich MA, Edelman ER. Arterial paclitaxel distribution and deposition. Circ Res. 2000;86:879-884.
21. Yoshida H, Nakamura M, Makita S, et al. Paracrine effect of human vascular endothelial cells on human vascular smooth muscle cell proliferation: transmembrane co-culture method. Heart Vessels. 1996;11:229-233.
22. Axel DI, Riessen R, Athanasiadis A, et al. Growth factor expression of human arterial smooth cells and endothelial cells in a transfilter coculture system. J Mol Cell Cardiol. 1997;29:2967-2978.
23. Rodgers CD. Drug-eluting stents: role of stent design, delivery vehicle, and drug selection. Rev Cardiovasc Med. 2002;3(Suppl 5):S10-S15.
24. Werner N, Junk S, Laufs U, et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res. 2003;93:17-24.
25. Schmeisser A, Strasser RH. Phenotypic overlap between hematopoietic cells with suggested angioblastic potential and vascular endothelial cells. J Hematother Stem Cell Res. 2002;11:69-79.
26. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res. 2004;95:343-353.
27. Oswald J, Boxberger S, Jorgensen B, et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells. 2004;22:377-384.
28. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res. 2004;95:9-20.
29. Chen SL, Fang WW, Ye F, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol. 2004;94:92-95.
30. Spees JL, Olson SD, Ylostalo J, et al. Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc Natl Acad Sci USA. 2003;100:2397-2402.
31. Sata M, Saiura A, Kunisato A, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 2002;8:403-409.
32. Bittira B, Kuang JQ, Al-Khaldi A, et al. In vitro preprogramming of marrow stromal cells for myocardial regeneration. Ann Thorac Surg. 2002;74:1154-1159.
33. Vittet D, Prandini MH, Berthier R, et al. Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. Blood. 1996;88:3424-3431.
34. Garlanda C, Dejana E. Heterogeneity of endothelial cells: specific markers. Arterioscler Thromb Vasc Biol. 1997;17:1193-1202.
35. Yamashita J, Itoh H, Hirashima M, et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature. 2000;408:92-96.